Lettmann Jason (CIK 1688269) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-18). Recent activity: Sell ALXO (2,230 shares), Sell ALXO (12,311 shares), Sell ALXO (2,201 shares), Buy ALXO (21,070 shares), Buy ALXO (71,163 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | ALX ONCOLOGY HOLDINGS INC (ALXO) | CHIEF EXECUTIVE OFFICER | Sell | 2,230 | $4,304 |
| 2026-03-23 | ALX ONCOLOGY HOLDINGS INC (ALXO) | CHIEF EXECUTIVE OFFICER | Sell | 12,311 | $26,715 |
| 2026-02-19 | ALX ONCOLOGY HOLDINGS INC (ALXO) | CHIEF EXECUTIVE OFFICER | Sell | 2,201 | $4,996 |
| 2025-09-18 | ALX ONCOLOGY HOLDINGS INC (ALXO) | CHIEF EXECUTIVE OFFICER | Buy | 21,070 | $22,545 |
| 2025-09-18 | ALX ONCOLOGY HOLDINGS INC (ALXO) | CHIEF EXECUTIVE OFFICER | Buy | 71,163 | $76,856 |
| 2025-08-19 | ALX ONCOLOGY HOLDINGS INC (ALXO) | CHIEF EXECUTIVE OFFICER | Sell | 2,382 | $1,524 |
| 2025-03-18 | ALX ONCOLOGY HOLDINGS INC (ALXO) | CHIEF EXECUTIVE OFFICER | Buy | 42,000 | $0 |
Source: SEC Form 4 filings · as of 2026-08-18